Procter & Gamble (NYSE:PG) Upgraded at DA Davidson

DA Davidson upgraded shares of Procter & Gamble (NYSE:PGFree Report) from a neutral rating to a buy rating in a research note released on Monday, MarketBeat.com reports. They currently have $209.00 price target on the stock, up from their previous price target of $160.00. DA Davidson also issued estimates for Procter & Gamble’s Q2 2025 earnings at $1.87 EPS, FY2025 earnings at $7.03 EPS and FY2026 earnings at $7.49 EPS.

PG has been the subject of a number of other reports. Barclays cut Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research note on Monday, September 30th. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Morgan Stanley raised their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Finally, StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $180.45.

Get Our Latest Analysis on Procter & Gamble

Procter & Gamble Price Performance

Shares of PG stock opened at $179.36 on Monday. The firm’s 50 day moving average price is $170.37 and its two-hundred day moving average price is $168.98. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. Procter & Gamble has a 52-week low of $142.50 and a 52-week high of $180.43. The stock has a market cap of $422.40 billion, a PE ratio of 30.92, a PEG ratio of 3.82 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same period in the previous year, the firm earned $1.83 earnings per share. The firm’s quarterly revenue was down .6% compared to the same quarter last year. As a group, analysts forecast that Procter & Gamble will post 6.96 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.24%. Procter & Gamble’s payout ratio is currently 69.48%.

Insider Transactions at Procter & Gamble

In related news, insider Susan Street Whaley sold 634 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the sale, the insider now owns 19,341 shares in the company, valued at approximately $3,319,882.65. This represents a 3.17 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the transaction, the insider now owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 35,233 shares of company stock worth $6,024,234 in the last three months. Insiders own 0.18% of the company’s stock.

Institutional Trading of Procter & Gamble

Large investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC increased its holdings in shares of Procter & Gamble by 7.0% during the 3rd quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company’s stock worth $9,538,327,000 after acquiring an additional 3,619,466 shares during the last quarter. FMR LLC increased its holdings in shares of Procter & Gamble by 2.7% in the third quarter. FMR LLC now owns 26,556,319 shares of the company’s stock valued at $4,599,554,000 after purchasing an additional 689,282 shares during the last quarter. Legal & General Group Plc raised its position in shares of Procter & Gamble by 0.6% in the second quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock valued at $3,567,556,000 after purchasing an additional 122,190 shares during the period. Franklin Resources Inc. lifted its stake in shares of Procter & Gamble by 10.2% during the 3rd quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company’s stock worth $3,290,573,000 after buying an additional 1,760,214 shares during the last quarter. Finally, Fisher Asset Management LLC boosted its holdings in shares of Procter & Gamble by 4.7% during the 3rd quarter. Fisher Asset Management LLC now owns 18,380,610 shares of the company’s stock worth $3,183,522,000 after buying an additional 830,476 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Company Profile

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.